[{"Assets_0_Q3_USD":121655000.0,"CommonStockSharesOutstanding_0_Q3_shares":47882897.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-55168000.0,"NetIncomeLoss_1_Q3_USD":-16792000.0,"NetIncomeLoss_3_Q3_USD":-11962000.0,"StockholdersEquity_0_Q3_USD":93045000.0,"Ticker":"MRSN","CIK":"1442836","name":"MERSANA THERAPEUTICS, INC.","OfficialName":"Mersana Therapeutics Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"345233797.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191106"}]